Ali Elbeddini

584 total citations
26 papers, 397 citations indexed

About

Ali Elbeddini is a scholar working on Geriatrics and Gerontology, Infectious Diseases and Emergency Medical Services. According to data from OpenAlex, Ali Elbeddini has authored 26 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Geriatrics and Gerontology, 6 papers in Infectious Diseases and 6 papers in Emergency Medical Services. Recurrent topics in Ali Elbeddini's work include Pharmaceutical Practices and Patient Outcomes (12 papers), Patient Safety and Medication Errors (6 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Ali Elbeddini is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (12 papers), Patient Safety and Medication Errors (6 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Ali Elbeddini collaborates with scholars based in United States, Canada and Türkiye. Ali Elbeddini's co-authors include Cindy Tran, Lucy Yang, Yueyang Zhou, Ahmed Aly, Stephanie J. Lee, Michelle Davey, Simon Duncan, Darren Tse and Orhan Yılmaz and has published in prestigious journals such as Research in Social and Administrative Pharmacy, Journal of Primary Care & Community Health and Journal of Diabetes & Metabolic Disorders.

In The Last Decade

Ali Elbeddini

26 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Elbeddini United States 11 119 114 105 71 70 26 397
Damian Świeczkowski Poland 13 144 1.2× 48 0.4× 92 0.9× 65 0.9× 66 0.9× 51 491
Antonio Poncel-Falcó Spain 8 162 1.4× 39 0.3× 94 0.9× 87 1.2× 42 0.6× 9 642
Casey Tak United States 14 82 0.7× 40 0.4× 106 1.0× 21 0.3× 214 3.1× 63 523
Sandra Benavides United States 12 277 2.3× 47 0.4× 118 1.1× 15 0.2× 145 2.1× 36 601
Kaitlyn E. Watson Canada 9 77 0.6× 41 0.4× 62 0.6× 34 0.5× 27 0.4× 45 280
Lucas A. Berenbrok United States 11 195 1.6× 22 0.2× 146 1.4× 59 0.8× 107 1.5× 37 574
Tim Schutte Netherlands 13 97 0.8× 14 0.1× 112 1.1× 29 0.4× 143 2.0× 25 459
Mervat Alsous Jordan 14 87 0.7× 52 0.5× 57 0.5× 32 0.5× 77 1.1× 47 535
Daphne Philbert Netherlands 14 227 1.9× 56 0.5× 220 2.1× 26 0.4× 39 0.6× 24 608
Mark Kingston United Kingdom 7 18 0.2× 46 0.4× 141 1.3× 56 0.8× 41 0.6× 24 347

Countries citing papers authored by Ali Elbeddini

Since Specialization
Citations

This map shows the geographic impact of Ali Elbeddini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Elbeddini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Elbeddini more than expected).

Fields of papers citing papers by Ali Elbeddini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Elbeddini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Elbeddini. The network helps show where Ali Elbeddini may publish in the future.

Co-authorship network of co-authors of Ali Elbeddini

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Elbeddini. A scholar is included among the top collaborators of Ali Elbeddini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Elbeddini. Ali Elbeddini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elbeddini, Ali, et al.. (2024). Assessing the efficacy of topical formulations in diabetic neuropathy: a narrative review. Journal of Diabetes & Metabolic Disorders. 23(2). 1613–1620. 2 indexed citations
2.
Elbeddini, Ali, et al.. (2021). Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study. Journal of Pharmaceutical Policy and Practice. 14(1). 19–19. 1 indexed citations
3.
Elbeddini, Ali, et al.. (2021). Evaluation of a community-based memory clinic in collaboration with local hospitals to support patients with memory decline. Journal of Taibah University Medical Sciences. 17(2). 220–234. 3 indexed citations
4.
Elbeddini, Ali, et al.. (2021). Fournier’s gangrene with dapagliflozin in a rural hospital: a case report. BMJ Case Reports. 14(2). e237784–e237784. 8 indexed citations
5.
Elbeddini, Ali, et al.. (2021). Avoiding a Med-Wreck: a structured medication reconciliation framework and standardized auditing tool utilized to optimize patient safety and reallocate hospital resources. Journal of Pharmaceutical Policy and Practice. 14(1). 10–10. 7 indexed citations
6.
Elbeddini, Ali, et al.. (2020). Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine. Journal of Pharmaceutical Policy and Practice. 13(1). 23–23. 47 indexed citations
7.
Elbeddini, Ali, et al.. (2020). Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic. Research in Social and Administrative Pharmacy. 17(1). 1942–1945. 24 indexed citations
8.
Elbeddini, Ali, et al.. (2020). Strategies to conserve salbutamol pressurized metered-dose inhaler stock levels amid COVID-19 drug shortage. Drugs & Therapy Perspectives. 36(10). 451–454. 8 indexed citations
9.
Elbeddini, Ali. (2020). Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage. Journal of Pharmaceutical Policy and Practice. 13(1). 19–19. 9 indexed citations
10.
Elbeddini, Ali, et al.. (2020). Mental health issues impacting pharmacists during COVID-19. Journal of Pharmaceutical Policy and Practice. 13(1). 46–46. 68 indexed citations
11.
12.
Elbeddini, Ali, et al.. (2020). Pharmacists and COVID-19. Journal of Pharmaceutical Policy and Practice. 13(1). 36–36. 71 indexed citations
13.
Elbeddini, Ali, et al.. (2020). Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy. Journal of Pharmaceutical Policy and Practice. 13(1). 73–73. 5 indexed citations
14.
Elbeddini, Ali, et al.. (2020). Amid COVID-19 pandemic: Challenges with access to care for COPD patients. Research in Social and Administrative Pharmacy. 17(1). 1934–1937. 26 indexed citations
15.
Elbeddini, Ali, et al.. (2020). Amid COVID-19 drug shortages: proposed plan for reprocessing and reusing salbutamol pressurized metered dose inhalers (pMDIs) for shared use. Drugs & Therapy Perspectives. 36(7). 300–302. 6 indexed citations
16.
Elbeddini, Ali, et al.. (2020). Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 153(4). 198–203. 17 indexed citations
17.
Tse, Darren, et al.. (2020). Evaluating an inpatient deprescribing initiative at a rural community hospital in Ontario. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 153(4). 224–231. 10 indexed citations
18.
Elbeddini, Ali, et al.. (2020). Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety. Journal of Pharmaceutical Policy and Practice. 13(1). 18–18. 6 indexed citations
19.
Elbeddini, Ali, et al.. (2020). A Case of Fournier’s Gangrene in a Patient Taking Canagliflozin for the Treatment of Type II Diabetes Mellitus. American Journal of Case Reports. 21. e920115–e920115. 11 indexed citations
20.
Elbeddini, Ali, et al.. (2019). The pharmacist’s role in successful deprescribing through hospital medication reconciliation. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 152(3). 177–179. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Damian Świeczkowski Breakdown of academic impact, for papers by Antonio Poncel-Falcó Breakdown of academic impact, for papers by Casey Tak Breakdown of academic impact, for papers by Sandra Benavides Breakdown of academic impact, for papers by Kaitlyn E. Watson Breakdown of academic impact, for papers by Lucas A. Berenbrok Breakdown of academic impact, for papers by Tim Schutte Breakdown of academic impact, for papers by Mervat Alsous Breakdown of academic impact, for papers by Daphne Philbert Breakdown of academic impact, for papers by Mark Kingston
Rankless by CCL
2026